{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:12:59Z","timestamp":1794035579113,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Council of Thailand (NRCT) and Mahidol University","award":["N42A650351"],"award-info":[{"award-number":["N42A650351"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01303-9","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T11:00:38Z","timestamp":1746702038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli"],"prefix":"10.1038","volume":"15","author":[{"given":"Chawalit","family":"Chatupheeraphat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noramon","family":"Kaewsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuttapat","family":"Anuwongcharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuleeporn","family":"Phanus-umporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarat","family":"Pornsuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warawan","family":"Eiamphungporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"1303_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404, 1199\u20131226 (2024).","journal-title":"Lancet"},{"key":"1303_CR2","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.24976\/Discov.Med.202436188.177","volume":"36","author":"AM Algammal","year":"2024","unstructured":"Algammal, A. M. & Behzadi, P. Antimicrobial resistance: A global public health concern that needs perspective combating strategies and new talented antibiotics. Discov Med. 36, 1911\u20131913 (2024).","journal-title":"Discov Med."},{"key":"1303_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/antibiotics13030257","volume":"13","author":"T Karampatakis","year":"2024","unstructured":"Karampatakis, T., Tsergouli, K. & Behzadi, P. Pan-genome plasticity and virulence factors: a natural treasure trove for Acinetobacter baumannii. Antibiot. (Basel). 13, 257 (2024).","journal-title":"Antibiot. (Basel)"},{"key":"1303_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/antibiotics14040353","volume":"14","author":"T Karampatakis","year":"2025","unstructured":"Karampatakis, T., Tsergouli, K. & Behzadi, P. Carbapenem-resistant Pseudomonas aeruginosa\u2019s resistome: pan-genomic plasticity, the impact of transposable elements and jumping genes. Antibiotics 14, 353 (2025).","journal-title":"Antibiotics"},{"key":"1303_CR5","unstructured":"List, W. B. Bacterial Pathogens of Public Health Importance To Guide Research, Development and Strategies To Prevent and Control Antimicrobial Resistance (World Health Organization, 2024)."},{"key":"1303_CR6","doi-asserted-by":"crossref","unstructured":"El-Sayed Ahmed, M. A. E. et al. Colistin and its role in the Era of antibiotic resistance: an extended review (2000\u20132019). Emerging microbes & infections. 9, 868\u2013885 (2020).","DOI":"10.1080\/22221751.2020.1754133"},{"key":"1303_CR7","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/microorganisms8111716","volume":"8","author":"FF Andrade","year":"2020","unstructured":"Andrade, F. F., Silva, D., Rodrigues, A. & Pina-Vaz, C. Colistin update on its mechanism of action and resistance, present and future challenges. Microorganisms 8, 1716 (2020).","journal-title":"Microorganisms"},{"key":"1303_CR8","doi-asserted-by":"publisher","first-page":"116833","DOI":"10.1016\/j.ejmech.2024.116833","volume":"279","author":"M Aggarwal","year":"2024","unstructured":"Aggarwal, M. et al. Drug repurposing against antibiotic resistant bacterial pathogens. Eur. J. Med. Chem. 279, 116833 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"1303_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fcimb.2019.00193","volume":"9","author":"L Peyclit","year":"2019","unstructured":"Peyclit, L., Baron, S. A. & Rolain, J. M. Drug repurposing to fight colistin and carbapenem-resistant bacteria. Front. Cell. Infect. Microbiol. 9, 193 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1303_CR10","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.7150\/thno.56205","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics 11, 4910\u20134928 (2021).","journal-title":"Theranostics"},{"key":"1303_CR11","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/iub.2266","volume":"72","author":"R Mirzaei","year":"2020","unstructured":"Mirzaei, R. et al. The biofilm-associated bacterial infections unrelated to indwelling devices. IUBMB Life. 72, 1271\u20131285 (2020).","journal-title":"IUBMB Life"},{"key":"1303_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/antibiotics5010003","volume":"5","author":"WR Abraham","year":"2016","unstructured":"Abraham, W. R. Going beyond the control of quorum-sensing to combat biofilm infections. Antibiot. (Basel). 5, 3 (2016).","journal-title":"Antibiot. (Basel)"},{"key":"1303_CR13","doi-asserted-by":"publisher","first-page":"e02192","DOI":"10.1016\/j.heliyon.2019.e02192","volume":"5","author":"G Gebreyohannes","year":"2019","unstructured":"Gebreyohannes, G., Nyerere, A., Bii, C. & Sbhatu, D. B. Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. Heliyon 5, e02192 (2019).","journal-title":"Heliyon"},{"key":"1303_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.15698\/mic2021.02.741","volume":"8","author":"A Schulze","year":"2021","unstructured":"Schulze, A., Mitterer, F., Pombo, J. P. & Schild, S. Biofilms by bacterial human pathogens: clinical relevance - development, composition and regulation - therapeutical strategies. Microb. Cell. 8, 28\u201356 (2021).","journal-title":"Microb. Cell."},{"key":"1303_CR15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/microorganisms9071353","volume":"9","author":"A Pompilio","year":"2021","unstructured":"Pompilio, A. et al. Gram-negative bacteria holding together in a biofilm: the Acinetobacter baumannii way. Microorganisms 9, 1353 (2021).","journal-title":"Microorganisms"},{"key":"1303_CR16","first-page":"172","volume":"13","author":"S Mishra","year":"2023","unstructured":"Mishra, S. et al. Therapeutic strategies against biofilm infections. Life (Basel). 13, 172 (2023).","journal-title":"Life (Basel)"},{"key":"1303_CR17","first-page":"113","volume":"23","author":"E Zur","year":"2019","unstructured":"Zur, E. Penfluridol, a unique psychiatric medicine for the treatment of chronic schizophrenia. Int. J. Pharm. Compd. 23, 113\u2013119 (2019).","journal-title":"Int. J. Pharm. Compd."},{"key":"1303_CR18","doi-asserted-by":"publisher","first-page":"e1148","DOI":"10.1002\/mbo3.1148","volume":"10","author":"X Zeng","year":"2021","unstructured":"Zeng, X. et al. Drug repurposing: antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis. MicrobiologyOpen 10, e1148 (2021).","journal-title":"MicrobiologyOpen"},{"key":"1303_CR19","doi-asserted-by":"publisher","first-page":"727692","DOI":"10.3389\/fmicb.2021.727692","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Antimicrobial, antibiofilm, and anti-persister activities of penfluridol against Staphylococcus aureus. Front. Microbiol. 12, 727692 (2021).","journal-title":"Front. Microbiol."},{"key":"1303_CR20","doi-asserted-by":"publisher","first-page":"1153868","DOI":"10.3389\/fcimb.2023.1153868","volume":"13","author":"C Chatupheeraphat","year":"2023","unstructured":"Chatupheeraphat, C., Peamchai, J., Luk-In, S. & Eiamphungporn, W. Synergistic effect and antibiofilm activity of the antimicrobial peptide K11 with conventional antibiotics against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae. Front. Cell. Infect. Microbiol. 13, 1153868 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1303_CR21","doi-asserted-by":"publisher","first-page":"e0294287","DOI":"10.1371\/journal.pone.0294287","volume":"18","author":"C Chatupheeraphat","year":"2023","unstructured":"Chatupheeraphat, C., Peamchai, J., Luk-In, S., Yainoy, S. & Eiamphungporn, W. Synergistic effect of two antimicrobial peptides, BP203 and MAP-0403 J-2 with conventional antibiotics against colistin-resistant Escherichia coli and Klebsiella pneumoniae clinical isolates. PLoS One. 18, e0294287 (2023).","journal-title":"PLoS One"},{"key":"1303_CR22","doi-asserted-by":"crossref","unstructured":"Gasteiger, E. et al. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31, 3784\u20133788 (2003).","DOI":"10.1093\/nar\/gkg563"},{"key":"1303_CR23","doi-asserted-by":"publisher","first-page":"W695","DOI":"10.1093\/nar\/gkq313","volume":"38","author":"M Goujon","year":"2010","unstructured":"Goujon, M. et al. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res. 38, W695\u2013699 (2010).","journal-title":"Nucleic Acids Res."},{"key":"1303_CR24","unstructured":"Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for bacteria that Grow Aerobically; Approved standard-eleventh Edition: M07-A10 (CLSI, 2018)."},{"key":"1303_CR25","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3389\/fmicb.2018.01808","volume":"9","author":"A Cannatelli","year":"2018","unstructured":"Cannatelli, A., Principato, S., Colavecchio, O. L., Pallecchi, L. & Rossolini, G. M. Synergistic activity of colistin in combination with Resveratrol against colistin-resistant Gram-negative pathogens. Front. Microbiol. 9, 1808 (2018).","journal-title":"Front. Microbiol."},{"key":"1303_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds, F. C. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52, 1 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"1303_CR27","doi-asserted-by":"publisher","first-page":"e0018422","DOI":"10.1128\/spectrum.00184-22","volume":"10","author":"Z Yao","year":"2022","unstructured":"Yao, Z. et al. Thymol increases sensitivity of clinical Col-R Gram-negative bacteria to colistin. Microbiol. Spectr. 10, e0018422 (2022).","journal-title":"Microbiol. Spectr."},{"key":"1303_CR28","unstructured":"National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents-approved guideline M26-A. NCCLS, Wayne, PA, USA. (1999)."},{"key":"1303_CR29","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.3389\/fmicb.2018.02864","volume":"9","author":"M Jangra","year":"2018","unstructured":"Jangra, M. et al. Purification, characterization and in vitro evaluation of polymyxin A from Paenibacillus dendritiformis: an underexplored member of the polymyxin family. Front. Microbiol. 9, 2864 (2018).","journal-title":"Front. Microbiol."},{"key":"1303_CR30","doi-asserted-by":"publisher","first-page":"e0216021","DOI":"10.1128\/spectrum.02160-21","volume":"10","author":"X Xiao","year":"2022","unstructured":"Xiao, X., Zeng, F., Li, R., Liu, Y. & Wang, Z. Subinhibitory concentration of colistin promotes the conjugation frequencies of mcr-1- and blaNDM-5-positive plasmids. Microbiol. Spectr. 10, e0216021 (2022).","journal-title":"Microbiol. Spectr."},{"key":"1303_CR31","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1093\/jac\/dks276","volume":"67","author":"JE Pollard","year":"2012","unstructured":"Pollard, J. E. et al. In vitro evaluation of the potential for resistance development to Ceragenin CSA-13. J. Antimicrob. Chemother. 67, 2665\u20132672 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"1303_CR32","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1128\/AAC.02473-13","volume":"58","author":"R Gopal","year":"2014","unstructured":"Gopal, R. et al. Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. Antimicrob. Agents Chemother. 58, 1622\u20131629 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1303_CR33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1099\/jmm.0.000945","volume":"68","author":"JX Zheng","year":"2019","unstructured":"Zheng, J. X. Et al. In vitro activities of daptomycin combined with fosfomycin or Rifampin on planktonic and adherent linezolid-resistant isolates of Enterococcus faecalis. J. Med. Microbiol. 68, 493\u2013502 (2019).","journal-title":"J. Med. Microbiol."},{"key":"1303_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jgar.2018.06.007","volume":"15","author":"W Eiamphungporn","year":"2018","unstructured":"Eiamphungporn, W. et al. Prevalence of the colistin resistance gene mcr-1 in colistin-resistant Escherichia coli and Klebsiella pneumoniae isolated from humans in Thailand. J. Glob Antimicrob. Resist. 15, 32\u201335 (2018).","journal-title":"J. Glob Antimicrob. Resist."},{"key":"1303_CR35","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1128\/AAC.00084-14","volume":"58","author":"A Jayol","year":"2014","unstructured":"Jayol, A. et al. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob. Agents Chemother. 58, 4762 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1303_CR36","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1128\/AAC.01480-13","volume":"57","author":"A Cannatelli","year":"2013","unstructured":"Cannatelli, A. et al. Vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ\/PhoP MgrB regulator. Antimicrob. Agents Chemother. 57, 5521\u20135526 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1303_CR37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1089\/mdr.2017.0397","volume":"24","author":"M Haeili","year":"2018","unstructured":"Haeili, M., Kafshdouz, M. & Feizabadi, M. M. Molecular mechanisms of colistin resistance among pandrug-resistant isolates of Acinetobacter baumannii with high case-fatality rate in intensive care unit patients. Microb. Drug Resist. 24, 1271\u20131276 (2018).","journal-title":"Microb. Drug Resist."},{"key":"1303_CR38","doi-asserted-by":"publisher","first-page":"8053","DOI":"10.1128\/JB.00834-08","volume":"190","author":"MD Adams","year":"2008","unstructured":"Adams, M. D. et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J. Bacteriol. 190, 8053\u20138064 (2008).","journal-title":"J. Bacteriol."},{"key":"1303_CR39","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"GBD 2021 Forecasting Collaborators","year":"2024","unstructured":"GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the global burden of disease study 2021. Lancet 403, 2204\u20132256 (2024).","journal-title":"Lancet"},{"key":"1303_CR40","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.3390\/molecules29132969","volume":"29","author":"E Diani","year":"2024","unstructured":"Diani, E., Bianco, G., Gatti, M., Gibellini, D. & Gaibani, P. Colistin: lights and shadows of an older antibiotic. Molecules 29, 2969 (2024).","journal-title":"Molecules"},{"key":"1303_CR41","doi-asserted-by":"publisher","first-page":"677720","DOI":"10.3389\/fmed.2021.677720","volume":"8","author":"FA Gogry","year":"2021","unstructured":"Gogry, F. A., Siddiqui, M. T., Sultan, I. & Haq Q.M.R. Current update on intrinsic and acquired colistin resistance mechanisms in bacteria. Front. Med. (Lausanne). 8, 677720 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"1303_CR42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1021\/acsinfecdis.7b00071","volume":"8","author":"RJ Melander","year":"2017","unstructured":"Melander, R. J. & Melander, C. The challenge of overcoming antibiotic resistance: an adjuvant approach? ACS Infect. Dis. 8, 559\u2013563 (2017).","journal-title":"ACS Infect. Dis."},{"key":"1303_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/1040841X.2019.1599813","volume":"45","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Li, R., Xiao, X. & Wang, Z. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria. Crit. Rev. Microbiol. 45, 301\u2013314 (2019).","journal-title":"Crit. Rev. Microbiol."},{"key":"1303_CR44","doi-asserted-by":"publisher","first-page":"106380","DOI":"10.1016\/j.ijantimicag.2021.106380","volume":"58","author":"VS Foletto","year":"2021","unstructured":"Foletto, V. S., da Rosa, T. F., Serafin, M. B., Bottega, A. & H\u00f6rner, R. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review. Int. J. Antimicrob. Agents. 58, 106380 (2021).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"1303_CR45","doi-asserted-by":"publisher","first-page":"1293633","DOI":"10.3389\/fcimb.2023.1293633","volume":"13","author":"V Kumar","year":"2023","unstructured":"Kumar, V. et al. Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens. Front. Cell. Infect. Microbiol. 13, 1293633 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1303_CR46","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.3390\/molecules24203659","volume":"24","author":"NM Tuan","year":"2019","unstructured":"Tuan, N. M. & Lee, C. H. Penfluridol as a candidate of drug repurposing for anticancer agent. Molecules 24, 3659 (2019).","journal-title":"Molecules"},{"key":"1303_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13075-021-02713-6","volume":"24","author":"YH Chen","year":"2022","unstructured":"Chen, Y. H. et al. Penfluridol targets acid Sphingomyelinase to inhibit TNF signaling and is therapeutic against inflammatory autoimmune diseases. Arthritis Res. Ther. 24, 27 (2022).","journal-title":"Arthritis Res. Ther."},{"key":"1303_CR48","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos, A. P. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268\u2013281 (2012).","journal-title":"Clin. Microbiol. Infect."},{"key":"1303_CR49","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.mjafi.2023.06.006","volume":"79","author":"B Prava Rout","year":"2023","unstructured":"Prava Rout, B., Behera, B., Kumar Sahu, K., Praharaj, I. & Otta, S. An overview of colistin resistance: a breach in last line defense. Med. J. Armed Forces India. 79, 516\u2013525 (2023).","journal-title":"Med. J. Armed Forces India"},{"key":"1303_CR50","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s40262-017-0561-1","volume":"56","author":"N Gr\u00e9goire","year":"2017","unstructured":"Gr\u00e9goire, N., Aranzana-Climent, V., Magr\u00e9ault, S., Marchand, S. & Couet, W. Clinical pharmacokinetics and pharmacodynamics of colistin. Clin. Pharmacokinet. 56, 1441\u20131460 (2017).","journal-title":"Clin. Pharmacokinet."},{"key":"1303_CR51","doi-asserted-by":"publisher","first-page":"14429","DOI":"10.1038\/s41598-023-39647-9","volume":"13","author":"M G\u00f3mara-Lomero","year":"2023","unstructured":"G\u00f3mara-Lomero, M., L\u00f3pez-Calleja, A. I., Rezusta, A., A\u00ednsa, J. A. & Ram\u00f3n-Garc\u00eda, S. Vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae. Sci. Rep. 13, 14429 (2023).","journal-title":"Sci. Rep."},{"key":"1303_CR52","doi-asserted-by":"publisher","first-page":"153946","DOI":"10.1016\/j.phymed.2022.153946","volume":"98","author":"G Song","year":"2022","unstructured":"Song, G. et al. Nordihydroguaiaretic acid reverses the antibacterial activity of colistin against MCR-1-positive bacteria in vivo\/in vitro by inhibiting MCR-1 activity and injuring the bacterial cell membrane. Phytomedicine 98, 153946 (2022).","journal-title":"Phytomedicine"},{"key":"1303_CR53","doi-asserted-by":"publisher","first-page":"916587","DOI":"10.3389\/fmicb.2022.916587","volume":"13","author":"M Xu","year":"2022","unstructured":"Xu, M. et al. Naringenin restores colistin activation against colistin-resistant gram-negative bacteria in vitro and in vivo. Front. Microbiol. 13, 916587 (2022).","journal-title":"Front. Microbiol."},{"key":"1303_CR54","doi-asserted-by":"publisher","first-page":"e0405222","DOI":"10.1128\/spectrum.04052-22","volume":"11","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Flufenamic acid, a promising agent for the sensitization of colistin-resistant gram-negative bacteria to colistin. Microbiol. Spectr. 11, e0405222 (2023).","journal-title":"Microbiol. Spectr."},{"key":"1303_CR55","doi-asserted-by":"publisher","first-page":"e0366622","DOI":"10.1128\/spectrum.03666-22","volume":"11","author":"J Kong","year":"2023","unstructured":"Kong, J. et al. Eugenol works synergistically with colistin against colistin-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae isolates by enhancing membrane permeability. Microbiol. Spectr. 11, e0366622 (2023).","journal-title":"Microbiol. Spectr."},{"key":"1303_CR56","doi-asserted-by":"publisher","first-page":"112873","DOI":"10.1016\/j.biopha.2022.112873","volume":"149","author":"K Yi","year":"2022","unstructured":"Yi, K. et al. Synergistic antibacterial activity of tetrandrine combined with colistin against MCR-mediated colistin-resistant Salmonella. Biomed. Pharmacother. 149, 112873 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"1303_CR57","doi-asserted-by":"publisher","first-page":"eadg4205","DOI":"10.1126\/sciadv.adg4205","volume":"9","author":"ZX Zhong","year":"2023","unstructured":"Zhong, Z. X. et al. Natural flavonoids disrupt bacterial iron homeostasis to potentiate colistin efficacy. Sci. Adv. 9, eadg4205 (2023).","journal-title":"Sci. Adv."},{"key":"1303_CR58","doi-asserted-by":"publisher","first-page":"e0145923","DOI":"10.1128\/spectrum.01459-23","volume":"11","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. An effective antimicrobial strategy of colistin combined with the Chinese herbal medicine Shikonin against colistin-resistant Escherichia coli. Microbiol. Spectr. 11, e0145923 (2023).","journal-title":"Microbiol. Spectr."},{"key":"1303_CR59","doi-asserted-by":"publisher","first-page":"1374910","DOI":"10.3389\/fmicb.2024.1374910","volume":"15","author":"T Ding","year":"2024","unstructured":"Ding, T. et al. Synergistic antibacterial effects of closantel and its enantiomers in combination with colistin against multidrug resistant gram-negative bacteria. Front. Microbiol. 15, 1374910 (2024).","journal-title":"Front. Microbiol."},{"key":"1303_CR60","doi-asserted-by":"publisher","first-page":"e65836","DOI":"10.7554\/eLife.65836","volume":"10","author":"A Sabnis","year":"2021","unstructured":"Sabnis, A. et al. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. Elife 10, e65836 (2021).","journal-title":"Elife"},{"key":"1303_CR61","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.00064-16","volume":"30","author":"L Poirel","year":"2017","unstructured":"Poirel, L., Jayol, A. & Nordmann, P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin. Microbiol. Rev. 30, 557\u2013596 (2017).","journal-title":"Clin. Microbiol. Rev."},{"key":"1303_CR62","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/03602537908993895","volume":"9","author":"BH Migdalof","year":"1979","unstructured":"Migdalof, B. H., Grindel, J. M., Heykants, J. J. & Janssen, P. A. Penfluridol: a neuroleptic drug designed for long duration of action. Drug Metab. Rev. 9, 281\u2013299 (1979).","journal-title":"Drug Metab. Rev."},{"key":"1303_CR63","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41467-018-04059-1","volume":"9","author":"E Wistrand-Yuen","year":"2018","unstructured":"Wistrand-Yuen, E. et al. Evolution of high-level resistance during low-level antibiotic exposure. Nat. Commun. 9, 1599 (2018).","journal-title":"Nat. Commun."},{"key":"1303_CR64","doi-asserted-by":"publisher","first-page":"e00355","DOI":"10.1128\/AAC.00355-19","volume":"63","author":"DJ Diekema","year":"2019","unstructured":"Diekema, D. J. et al. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob. Agents Chemother. 63, e00355 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1303_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13756-024-01376-7","volume":"13","author":"N Bostanghadiri","year":"2024","unstructured":"Bostanghadiri, N. et al. Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis. Antimicrob. Resist. Infect. Control. 13, 24 (2024).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"1303_CR66","doi-asserted-by":"publisher","first-page":"1477836","DOI":"10.3389\/fmicb.2024.1477836","volume":"15","author":"N Narimisa","year":"2024","unstructured":"Narimisa, N. et al. Prevalence of colistin resistance in clinical isolates of Pseudomonas aeruginosa: a systematic review and meta-analysis. Front. Microbiol. 15, 1477836 (2024).","journal-title":"Front. Microbiol."},{"key":"1303_CR67","doi-asserted-by":"publisher","first-page":"e13508","DOI":"10.1111\/apm.13508","volume":"133","author":"N Li","year":"2025","unstructured":"Li, N., Ebrahimi, E., Sholeh, M., Dousti, R. & Kouhsari, E. A systematic review and meta-analysis: rising prevalence of colistin resistance in ICU-acquired Gram-negative bacteria. APMIS 133, e13508 (2025).","journal-title":"APMIS"},{"key":"1303_CR68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/antibiotics9020059","volume":"9","author":"LK Vestby","year":"2020","unstructured":"Vestby, L. K., Gr\u00f8nseth, T., Simm, R. & Nesse, L. L. Bacterial biofilm and its role in the pathogenesis of disease. Antibiot. (Basel). 9, 59 (2020).","journal-title":"Antibiot. (Basel)"},{"key":"1303_CR69","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/bmj.4.5789.710","volume":"4","author":"HM van Praag","year":"1971","unstructured":"van Praag, H. M., Schut, T., Dols, L. & van Schilfgaarden, R. Controlled trial of penfluridol in acute psychosis. Br. Med. J. 4, 710\u2013713 (1971).","journal-title":"Br. Med. J."},{"key":"1303_CR70","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1158\/0008-5472.CAN-15-1233","volume":"76","author":"A Ranjan","year":"2016","unstructured":"Ranjan, A., Gupta, P. & Srivastava, S. K. Penfluridol: an antipsychotic agent suppresses metastatic tumor growth in triple-negative breast cancer by inhibiting integrin signaling axis. Cancer Res. 76, 877\u2013890 (2016).","journal-title":"Cancer Res."},{"key":"1303_CR71","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.bmcl.2018.10.036","volume":"28","author":"M Ashraf-Uz-Zaman","year":"2018","unstructured":"Ashraf-Uz-Zaman, M., Sajib, M. S., Cucullo, L., Mikelis, C. M. & German, N. A. Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity. Bioorg. Med. Chem. Lett. 28, 3652\u20133657 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1303_CR72","first-page":"CD011831","volume":"9","author":"N Nikvarz","year":"2017","unstructured":"Nikvarz, N., Vahedian, M. & Khalili, N. Chlorpromazine versus penfluridol for schizophrenia. Cochrane Database Syst. Rev. 9, CD011831 (2017).","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01303-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01303-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01303-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:03:14Z","timestamp":1746705794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01303-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1303"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01303-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16114"}}